GlassScriptPhysician profile
Darlene Guin Johnson
NPI 1104851815
$2,352.98
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $876 · 2020: $829 · 2021: $647.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $526.28 | 2019-2021 | |
| Lilly USA, LLC | $422.23 | 2019-2021 | |
| Novo Nordisk INC | $236.45 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $228.35 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $167.61 | 2019-2021 | |
| Esperion Therapeutics, INC. | $118.85 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $113.84 | 2019-2020 | |
| Eisai INC. | $95.34 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $90.89 | 2019-2020 | |
| Abbvie INC. | $88.07 | 2020-2021 | |
| Amarin Pharma, INC. | $57.13 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $50.00 | 2020-2021 | |
| Allergan, INC. | $30.37 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $24.43 | 2021 | |
| Genentech USA, INC. | $24.16 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $23.19 | 2019 | |
| Pfizer INC. | $15.38 | 2019 | |
| Glaxosmithkline, LLC. | $14.07 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.67 | 2020 | |
| Zyla Life Sciences, INC. | $12.67 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darlene Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.